Behavior in subcortical vascular dementia with sight pathologies: visual hallucinations as a consequence of precocious gait imbalance and institutionalization.

Behavior disorder Gait disorders Institutionalization Ocular pathologies Subcortical vascular dementia Visual hallucinations

Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 20 08 2019
accepted: 25 04 2020
pubmed: 15 5 2020
medline: 15 5 2021
entrez: 15 5 2020
Statut: ppublish

Résumé

Subcortical vascular dementia (sVAD) is considered the most frequent dementia in old population, and it is due to a small vessel disease. It has a very specific nosography, where the dominant factors are dysexecutive functions, depression, and apathy. Very few studies described visual hallucinations in sVAD, apart from in the final stages of it. This study recruited 577 patients with a diagnosis of sVAD associated with major ocular pathologies and 1118 patients with sVAD without any significant ocular pathology: Patients were followed up for 24 months. We studied the influence of ocular pathologies in precocious visual hallucinations, on behavior disorder (aggressiveness), and gait disorders (instability, fells). We registered the necessity of neuropsychiatric therapies, incidence of hospitalization, and institutionalization. What emerges from our study is that the ocular comorbidities might change the behavior profile of dementia, provoking behavioral alterations, and the need for therapies with adverse effects. As far as old age is a complicated status of life, many factors can modify its development. The possible contribution of multiple biological events cannot be neglected, particularly the underlying influence of chronic diseases as well as the geriatric conditions, per se, might compromise the cognitive functions and the pathological conditions. Ocular pathology as a superimposing event in sVAD might worse the outcome. A correct and rapid identification of critical patients might be relevant for the dynamic life events in these patients and their caregivers.

Sections du résumé

BACKGROUND BACKGROUND
Subcortical vascular dementia (sVAD) is considered the most frequent dementia in old population, and it is due to a small vessel disease. It has a very specific nosography, where the dominant factors are dysexecutive functions, depression, and apathy. Very few studies described visual hallucinations in sVAD, apart from in the final stages of it.
METHODS METHODS
This study recruited 577 patients with a diagnosis of sVAD associated with major ocular pathologies and 1118 patients with sVAD without any significant ocular pathology: Patients were followed up for 24 months. We studied the influence of ocular pathologies in precocious visual hallucinations, on behavior disorder (aggressiveness), and gait disorders (instability, fells). We registered the necessity of neuropsychiatric therapies, incidence of hospitalization, and institutionalization.
RESULTS RESULTS
What emerges from our study is that the ocular comorbidities might change the behavior profile of dementia, provoking behavioral alterations, and the need for therapies with adverse effects. As far as old age is a complicated status of life, many factors can modify its development. The possible contribution of multiple biological events cannot be neglected, particularly the underlying influence of chronic diseases as well as the geriatric conditions, per se, might compromise the cognitive functions and the pathological conditions. Ocular pathology as a superimposing event in sVAD might worse the outcome. A correct and rapid identification of critical patients might be relevant for the dynamic life events in these patients and their caregivers.

Identifiants

pubmed: 32405881
doi: 10.1007/s10072-020-04445-y
pii: 10.1007/s10072-020-04445-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3283-3292

Références

Congdon N, O’Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P, Eye Diseases Prevalence Research Group (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122(4):477–485. https://doi.org/10.1001/archopht.122.4.477
doi: 10.1001/archopht.122.4.477
Berger S, Porell F (2008) The association between low vision and function. J Aging Health 20(5):504–525. https://doi.org/10.1177/0898264308317534
doi: 10.1177/0898264308317534 pubmed: 18436856
Vision (2020) UK dementia and sight loss group: wearing glasses with dementia factsheet. Public website. http://tinyurl.com/nqgmohq and http://tinyurl.com/m5ptgoy
Colenbrander A (2003) Aspect of vision loss: visual functions and functional vision. Vis Impair Res 5(3):115–136. https://doi.org/10.1080/1388235039048919
doi: 10.1080/1388235039048919
Pal A, Biswas A, Pandit A, Roy A, Guin D, Gangopadhyay G, Senapati AK (2016) Study of visuospatial skill in patients with dementia. Ann Indian Acad Neurol 19(1):83–88. https://doi.org/10.4103/0972-2327.168636
doi: 10.4103/0972-2327.168636 pubmed: 27011635 pmcid: 4782559
Collerton D, Perry E, McKeith I (2005) Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci 28(6):737–794. https://doi.org/10.1017/S0140525X05000130
doi: 10.1017/S0140525X05000130 pubmed: 16372931
Chui H (2001) Dementia associated with subcortical ischemic vascular disease. American Academy (AAN)-CD ROM, Philadelphia, USA. 2FC.005:89–101
Jelllinger KA (2013) Pathology and pathogenesis of vascular cognitive impairment - a critical update. Front Aging Neurosci 10(5):17. https://doi.org/10.3389/fnagi.2013.00017
doi: 10.3389/fnagi.2013.00017
Chase TN (2011) Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment. Neurotox Res 19(2):266–278. https://doi.org/10.1007/s12640-010-9196-9
doi: 10.1007/s12640-010-9196-9 pubmed: 20473601
Ballard C, Neill D, O’Brien JO, McKeith IG, Ince P, Perry R (2000) Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord 59(2):97–106. https://doi.org/10.1016/S0165-0327(99)00057-9
doi: 10.1016/S0165-0327(99)00057-9 pubmed: 10837878
Staekenborg SS, Su T, van Straaten ECW, Lane R, Scheltens P, Barkhof F, van der Flier WM (2010) Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. J Neurol Neurosurg Psychiatry 81(5):547–551. https://doi.org/10.1136/jnnp.2009.187500
doi: 10.1136/jnnp.2009.187500 pubmed: 19965852
Alexopoulos GS (2003) Role of executive function in late-life depression. J Clin Psychiatry 64(S14):18–23
pubmed: 14658931
Aizenstein HJ, Baskys A, Boldrini M, Butters MA, Diniz BS, Jaiswal MK, Jellinger KA, Kruglov LS, Meshandin IA, Mijajlovic MD, Niklewski G, Pospos S, Raju K, Richter K, Steffens DC, Taylor WD, Tene O (2016) Vascular depression consensus report - a critical update. BMC Med 3-14:161. https://doi.org/10.1186/s12916-016-0720-5
doi: 10.1186/s12916-016-0720-5
Kazui H, Yoshiyama K, Kanemoto H, Suzuki Y, Sato S, Hashimoto M, Ikeda M, Tanaka H, Hatada Y, Matsushita M, Nishio Y, Mori E, Tanimukai S, Komori K, Yoshida T, Shimizu H, Matsumoto T, Mori T, Kashibayashi T, Yokoyama K, Shimomura T, Kabeshita Y, Adachi H, Tanaka T (2016) Differences of behavioral and psychological symptoms of dementia in disease severity in four major dementias. PLoS One 11(8):e0161092. https://doi.org/10.1371/journal.pone.0161092
doi: 10.1371/journal.pone.0161092 pubmed: 27536962 pmcid: 4990196
Frederiksen KS, Waldemar G (2016) Aggression, agitation, hyperactivity, and irritability”. Springer Verlag Berlin. Neuropsychiatric Symptoms of Cognitive Impairment and Dementia (book NSND), pp 199–236
Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(9):2672–2713. https://doi.org/10.1161/STR.0b013e3182299496
doi: 10.1161/STR.0b013e3182299496 pubmed: 21778438 pmcid: 3778669
Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, O’Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43(2):250–260. https://doi.org/10.1212/wnl.43.2.250
doi: 10.1212/wnl.43.2.250 pubmed: 8094895
Erkinjuntti T (1997) Vascular dementia: challenge of clinical diagnosis. Int Psychogeriatr 9:51–58. https://doi.org/10.1017/S1041610297004699
doi: 10.1017/S1041610297004699 pubmed: 9447427
Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 42(3 Pt 1):473–480. https://doi.org/10.1212/wnl.42.3.473
doi: 10.1212/wnl.42.3.473 pubmed: 1549205
Erkinjuntti T, Ketonen L, Sulkava R, Vuorialho M, Palo J (1987) CT in the differential diagnosis between Alzheimer’s disease and vascular dementia. Acta Neurol Scand 75(4):262–270. https://doi.org/10.1111/j.1600-0404.1987.tb07931.x
doi: 10.1111/j.1600-0404.1987.tb07931.x pubmed: 3591276
Kim GH, Lee JH, Seo SW, Ye BS, Cho H, Kim HJ, Noh Y, Yoon CW, Chin JH, Oh SJ, Kim JS, Choe YS, Lee KH, Kim ST, Jeong JH, Na DL (2014) Seoul criteria for PIB(−) subcortical vascular dementia based on clinical and MRI variables. Neurology 82(17):1529–1535. https://doi.org/10.1212/WNL.0000000000000360
doi: 10.1212/WNL.0000000000000360 pubmed: 24682969
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmermann RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol 149(2):351–356. https://doi.org/10.2214/ajr.149.2.351
doi: 10.2214/ajr.149.2.351
Cleutjens FAHM, Ponds RWHM, Spruit MA, Burgmans S, Jacobs HIL, Gronenshild EHBM, Stalls J, Franssen FME, Dijkstra JB, Vanfleteren LEDW, Hofman PA, Wouters EFM, Janssen DJA (2017) The relationship between cerebral small vessel disease, hippocampal volume and cognitive functioning in patients with COPD: an MRI study. Front Aging Neurosci 9:88. https://doi.org/10.3389/fnagi.2017.00088
doi: 10.3389/fnagi.2017.00088 pubmed: 28424613 pmcid: 5371656
Olsson E, Byberg L, Karlstrom B, Cederholm T, Melhus H, Sjogren P, Kilander L (2017) Vitamin D is not associated with incident dementia or cognitive impairment: an 18-y follow-up study in community-living old men. Am J Clin Nutr 105(4):936–943. https://doi.org/10.3945/ajcn.116.141531
doi: 10.3945/ajcn.116.141531 pubmed: 28202477
Marshall GA, Shchelchkov E, Kaufer DI, Ivanco LS, Bohnen NI (2006) White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia. Acta Neurol Scand 113(2):87–91. https://doi.org/10.1111/j.1600-0404.2005.00553.x
doi: 10.1111/j.1600-0404.2005.00553.x pubmed: 16411968
Blennow K, Wallin A, Uhlemann C, Gottfries CG (1991) White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand 83(3):187–193. https://doi.org/10.1111/j.1600-0404.1991.tb04675.x
doi: 10.1111/j.1600-0404.1991.tb04675.x pubmed: 2031453
Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J (1993) A semiquantative rating scale for the assessment of signal scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114(1):7–12. https://doi.org/10.1016/0022-510X(93)90041-V
doi: 10.1016/0022-510X(93)90041-V pubmed: 8433101
Hughes CP, Berg L, Danzinger WL, Coben LA, Martin RL (1982) A new scale for the staging of dementia. Br J Psychiatry 140:566–572. https://doi.org/10.1192/bjp.140.6.566
doi: 10.1192/bjp.140.6.566 pubmed: 7104545
Folstein MF, Folstein SE, McHugh PR (1975) "mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198. https://doi.org/10.1016/0022-3956(75)90026-6
doi: 10.1016/0022-3956(75)90026-6
Dubois B, Slachevsky A, Litvan I, Pillon B (2000) A frontal assessment battery at bedside. Neurology 55(11):1621–1626. https://doi.org/10.1212/WNL.55.11.1621
doi: 10.1212/WNL.55.11.1621 pubmed: 11113214
Ott BR, Lafleche G, Whelihan WM, Buongiorno GW, Albert MS, Fogel BS (1996) Impaired awareness of deficits in Alzheimer disease. Alzheimer Dis Assoc Disord 10(2):68–76
doi: 10.1097/00002093-199601020-00003
Roncone R, Tozzini C, Mazza M, De Risio A, Giosué P, Morosini PL, Casacchia M (2003) Validation of the Italian version of the self-report insight scale. Epidemiol Psichiatr Soc 12(1):63–75
doi: 10.1017/S1121189X00006060
Ryden MB (1998) Aggressive behavior in persons with dementia who live in the community. Alzheimer Dis Assoc Disord 2(4):342–355
doi: 10.1097/00002093-198802040-00003
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory comprehensive assessment of psychopathology in dementia. Neurology 44(12):2308–2314
doi: 10.1212/WNL.44.12.2308
Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the apathy evaluation scale. Psychiatry Res 38(2):143–162. https://doi.org/10.1016/0165-1781(91)90040-V
doi: 10.1016/0165-1781(91)90040-V pubmed: 1754629
Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61–65
pubmed: 14258950
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3):179–186. https://doi.org/10.1093/geront/9.3_Part_1.179
doi: 10.1093/geront/9.3_Part_1.179 pubmed: 5349366
Tinetti ME (1986) Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 34(2):119–126. https://doi.org/10.1111/j.1532-5415.1986.tb05480.x
doi: 10.1111/j.1532-5415.1986.tb05480.x pubmed: 3944402
Srikanth S, Nagaraja AV, Ratnavalli E (2005) Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer’s disease, vascular dementia and frontotemporal dementia. J Neurol Sci 236(1–2):43–48. https://doi.org/10.1016/j.jns.2005.04.014
doi: 10.1016/j.jns.2005.04.014 pubmed: 15964021
Moretti R, Torre P, Antonello RM, Cazzato G (2006) Behavioral alterations and vascular dementia. Neurologist 12(1):43–47. https://doi.org/10.1097/01.nrl.0000186806.54314.e8
doi: 10.1097/01.nrl.0000186806.54314.e8 pubmed: 16547446
Caputo M, Monastero R, Marian E, Santucci A, Mangialasche F, Camarda R, Senin U, Mecocci P (2008) Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types. Acta Psychiatr Scand 117(6):455–464. https://doi.org/10.1111/j.1600-0447.2008.01175.x
doi: 10.1111/j.1600-0447.2008.01175.x pubmed: 18363771
Fuh JL, Wang SJ, Cummings JL (2005) Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia. J Neurol Neurosurg Psychiatry 76(10):1337–1341. https://doi.org/10.1136/jnnp.2004.056408
doi: 10.1136/jnnp.2004.056408 pubmed: 16170072 pmcid: 1739372
Bandyopadhyay TK, Biswas A, Roy A, Guin DS, Gangopadhyay G, Sarkhel S, Ghoshal MK, Senapati AK (2014) Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia. Ann Indian Acad Neurol 17(3):325–330. https://doi.org/10.4103/0972-2327.138520
doi: 10.4103/0972-2327.138520 pubmed: 25221405 pmcid: 4162022
Kim J, Schweizer TA, Fischer CE, Munoz DG (2017) The role of cerebrovascular disease on cognitive and functional status and psychosis in severe AD. J Alzheimers Dis 55(1):381–389. https://doi.org/10.3233/JAD-160506
doi: 10.3233/JAD-160506 pubmed: 27662301
Fischer CE, Qian W, Schweizer TA, Millikin CP, Ismail Z, Smith EE, Lix LM, Shelton P, Munoz DG (2015) Lewy bodies, vascular risk factors, and subcortical arteriosclerotic leukoencephalopathy, but not AD pathology are associated with development of psychosis in AD. J Alzheimers Dis 50(1):283–295. https://doi.org/10.3233/JAD-150606
doi: 10.3233/JAD-150606 pmcid: 4844451
Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA (2011) Microinfarct pathology, dementia and cognitive systems. Stroke 42(3):722–727. https://doi.org/10.1161/STROKEAHA.110.595082
doi: 10.1161/STROKEAHA.110.595082 pubmed: 21212395 pmcid: 3042494
Iadecola C (2013) The pathobiology of vascular dementia. Neuron 80(4):844–866. https://doi.org/10.1016/j.neuron.2013.10.008
doi: 10.1016/j.neuron.2013.10.008 pubmed: 24267647 pmcid: 24267647

Auteurs

Rita Moretti (R)

Department of Medical Surgical and Health Sciences, Cattinara Hospital Trieste, University of Trieste, Strada di Fiume, 447, Trieste, Italy.

Paola Caruso (P)

Department of Medical Surgical and Health Sciences, Cattinara Hospital Trieste, University of Trieste, Strada di Fiume, 447, Trieste, Italy. caruso.paola1983@libero.it.

Benedetta Storti (B)

Department of Medical Surgical and Health Sciences, Cattinara Hospital Trieste, University of Trieste, Strada di Fiume, 447, Trieste, Italy.

Riccardo Saro (R)

Department of Medical Surgical and Health Sciences, Cattinara Hospital Trieste, University of Trieste, Strada di Fiume, 447, Trieste, Italy.

Benedetta Kassabian (B)

Department of Medical Surgical and Health Sciences, Cattinara Hospital Trieste, University of Trieste, Strada di Fiume, 447, Trieste, Italy.

Alessia Sala (A)

Department of Medical Surgical and Health Sciences, Cattinara Hospital Trieste, University of Trieste, Strada di Fiume, 447, Trieste, Italy.

Anna Giannini (A)

Department of Medical Surgical and Health Sciences, Cattinara Hospital Trieste, University of Trieste, Strada di Fiume, 447, Trieste, Italy.

Silvia Gazzin (S)

Italian Liver Foundation, Science Park, Trieste, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH